Product Images Doxorubicin Hydrochloride

This is a tabular output of different clinical trials from various countries using different doxorubicin (DOXO) and non-doxorubicin-based (CMF) treatments. The table shows the hazard ratios and 95% confidence intervals for each trial. One trial shows that DOXO is better than CMF, while another trial shows that DOXO is worse than CMF. The boundary for non-inferiority with CMF is also given in the table.*

The text is discussing the hazard ratio and presenting a comparison of different studies on cancer treatment. It includes abbreviations of study names from different countries and mentions that 6 studies using Doxo-based treatment have been done. It also states that in some cases, Doxo was found to be better than OF, while in other cases, it was worse than OMF.*

This is a description of a medication called DOXOrubicin Hydrochloride Injection USP. It is a sterile solution containing 200mg/100mL (2mg/mL) of the drug. The medication is administered intravenously and it is nonpyrogenic and preservative-free. The bottle is a multi-dose vial that should be stored under refrigeration. The vial is not made with natural rubber latex. The medication should not be prescribed without a thorough knowledge of dose, indications, and toxicity. The text also includes a warning for potential tissue damage if the medication leaks outside the veins during administration. The manufacturer is Northstar Rx LLC, and it was manufactured in Romania.*